Policies & Guidelines

Asset Publisher

print Print Back Back Policy Number: MP-91085

print Print Back Back Policy Number: MP-91128

print Print Back Back Policy Number: MP-991091

Mandatory Drug Wastage Program

Actemra; Tofidence; Tyenne; Avtozma; Tocilizumab-anoh

H.P. Acthar, Cortrophin

Aldurazyme

Benlysta IV

Berinert

Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu

Cerezyme

Cimzia

Elaprase

print Print Back Back Hemophilia Products - Factor VIII Prior Authorization Program Summary Policy Number:...

Fosaprepitant: Emend®; Fosaprepitant Ψ; Focinvez Ψ

Fabrazyme

Aralast NP; Glassia; Prolastin-C; Zemaira®

Hizientra, Gammagard Liquid, Gamunex-C, Gammaked, Hyqvia, Cuvitru, Cutaquig, Xembify

Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, TriVisc, VISCO-3, Triluron, sodium hyaluronate 1%

Alyglo, Bivigam, Flebogamma, Gamunex-C, Gammagard Liquid, Gammagard S/D, Gammaked, Gammaplex, Octagam, Privigen, Panzyga